CLDN4: Williams-Beuren syndrome chromosomal region 8 protein鈥攁 potential drug target

Target Name: CLDN4

NCBI ID: G1364

CLDN4

CLDN4: Williams-Beuren syndrome chromosomal region 8 protein鈥攁 potential drug target

Williams-Beuren syndrome (WBS) is a rare genetic disorder characterized by the deletion of chromosomal region 8. WBS is a chromosomal structural variation that usually consists of three parts: 1p, 2p and 5p. In this variant, parts of the 1p and 2p regions are deleted, resulting in a reduced number of genes in this region. The 5p area is relatively normal.

Although the cause of Williams-Beuren syndrome is not fully understood, research suggests that the disease is associated with abnormal expression of multiple proteins. Among them, the Williams-Beuren syndrome chromosomal region 8 protein (CLDN4) is considered a potential drug target for WBS.

CLDN4 is a protein belonging to the integrin family and is expressed in a variety of tissues and organs. It plays an important role in cell signal transduction, cell adhesion and cell migration. In WBS patients, the expression level of CLDN4 is often abnormal.

Studies have found that variations in the CLDN4 gene are positively correlated with the severity and progression of WBS. This suggests that CLDN4 plays a key role in the development of WBS. At the same time, since WBS is a genetic disease, studying the application of CLDN4 in the treatment of WBS is also of great clinical significance.

As a drug target, CLDN4 provides new ideas for drug research and development. By inhibiting the activity of CLDN4, the activity of the WBS virus in WBS patients can be reduced, thereby improving the severity and progression of the disease. In addition, CLDN4 can also be used as a biomarker for WBS for diagnosis and prognosis.

Currently, some research teams have begun to explore the application of CLDN4 in the treatment of WBS. For example, researchers inhibited the activity of WBS virus in animal models by knocking out and overexpressing the CLDN4 gene, demonstrating the potential of CLDN4 in the treatment of WBS. In addition, some research teams have also found that the expression level of CLDN4 is closely related to the quality of life and health status of WBS patients, so the prognosis of WBS patients can be assessed by monitoring the expression level of CLDN4.

In conclusion, CLDN4 is a potential drug target for the treatment of WBS. Future studies should further explore the application of CLDN4 in the treatment of WBS, as well as the role of CLDN4 in the development and prognosis of WBS. At the same time, more studies should be conducted to evaluate the actual value of CLDN4 as a biomarker and drug target for WBS.

Protein Name: Claudin 4

Functions: Channel-forming tight junction protein that mediates paracellular chloride transport in the kidney. Plays a critical role in the paracellular reabsorption of filtered chloride in the kidney collecting ducts. Claudins play a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity

The "CLDN4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CLDN4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets